Home

Thomas Pike

CIK 1471570 · Chief Executive Officer · last filed 2026-09-02

Thomas Pike is a Chief Executive Officer who has filed 46 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing shows the insider was granted $34.2K of MLM on Sep 2, 2026. Across all open-market trades the lifetime net is +$549.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $22.3M across reported positions. 2 SEC filings were submitted jointly with LABORATORY CORP OF AMERICA HOLDINGS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22.33M

Companies

5

Total Filings

46

Lifetime Open-Market Net

$549.4K

Filer Profile

Reported Address
C/O MARTIN MARIETTA MATERIALS, INC.
4123 PARKLAKE AVENUE
RALEIGH, NC 27612
Related Filers
LABORATORY CORP OF AMERICA HOLDINGS — 2 joint filings, latest 2023-01-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MLM Director 5,029 $509.96 $2.56M $0 31 2026-09-02
FTRE Chief Executive Officer 171,136 $17.20 $2.94M $549.4K 9 2025-03-21
LH Pres & CEO Clinical Business — $311.54 — $0 1 2023-01-11
Q Vice Chair, Pres R&D Solutions 124,936 $126.40 $15.79M $0 3 2016-10-04
ACN Chief Risk Officer 5,614 $183.90 $1.03M $0 1 2009-11-18

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-02 MLM Grant (A) +66 $34.2K EDGAR
2026-06-02 MLM Grant (A) +59 $34.3K EDGAR
2026-05-18 MLM Grant (A) +313 $0 EDGAR
2026-03-02 MLM Grant (A) +47 $31.8K EDGAR
2025-12-01 MLM Grant (A) +51 $31.8K EDGAR
2025-09-02 MLM Grant (A) +51 $31.4K EDGAR
2025-06-03 MLM Grant (A) +58 $31.8K EDGAR
2025-05-16 MLM Grant (A) +308 $170.3K EDGAR
2025-03-21 FTRE Grant (A) — $0 EDGAR
2025-03-03 MLM Grant (A) +65 $31.4K EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.